secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ardent Health, Inc. (ARDT)
CIK:        0001756655
Form:       8-K
Filed at:   2025-01-13T23:59:59+00:00
Accession:  0001628280-25-001368
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 7.01, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ardent Health provides preliminary 2025 guidance; CMS approves NM directed payment program
--------------------------------------------------------------------------------

- CMS approved New Mexico directed payment program for July-December 2024; material Q4 financial benefit expected, amount not yet disclosed.
- Preliminary 2025 guidance: revenue growth mid-single digits plus ~$200M from NM and OK programs; adj. EBITDA mid-single digits plus ~$140M incremental.
- CEO Martin Bonick new base salary $1,076,000; CFO Alfred Lumsdaine base salary $628,000 under amended employment agreements effective Jan 10, 2025.
- CEO severance: 2x (salary + target bonus) for non-CIC, 3x for CIC; CFO severance: 1.5x non-CIC, 2x for CIC.
- Management reiterates intent to provide formal 2025 guidance in February 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1756655/000162828025001368/0001628280-25-001368-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1756655/000162828025001368/ardt-20250113.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-001368

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer